GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_16530/2025

STADAPHARM GmbH v. ACCORD HEALTHCARE S.L.U., ACCORD HEALTHCARE LIMITED,, Novartis AG, ACCORD HEALTHCARE B.V.

Datum
2025-04-14
Kammer
Luxembourg (LU)
Verfahrensart
Appeal RoP220.2
Sprache
EN

Metadaten

Fall-IDORD_16530-2025-953a825ebb27
Aktenzeichen
RegisterzeichenORD_16530/2025
EntscheidungsreferenzORD_16530/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

1 DECISION of the Court of Appeal of the Unified Patent Court issued on 14 April 2025 concerning public access to the register (R.262.1(b) RoP) KEYWORDS: - Public access to written pleadings and evidence, R.262.1(b) RoP APPELLANT /APPLICANT BEFORE THE COURT OF FIRST INSTANCE STADAPHARM GmbH, Stadastraße 2-18, 61118 Bad Vilbel, Germany (hereinafter: Stadapharm) represented by: Dr. Jan Phillip Rektorschek, attorney at law, Taylor Wessing, Munich, Germany, and other representatives from that firm RESPONDENTS / CLAIMANTS IN THE MAIN PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE 1. ACCORD HEALTHCARE B.V., Winthontlaan 200, 3526 KV, Utrecht, Netherlands 2. ACCORD HEALTHCARE S.L.U., Edificio Este, Planta 6, World Trade Center, Moll de Barcelona S/N, 08039 Barcelona, Spain 3. ACCORD HEALTHCARE LIMIT ...